Biotech

All Articles

ArsenalBio increases $325M, pivots off of past lead resource

.Toolbox Biosciences is actually carrying on up. The tissue treatment provider has actually added $3...

Lilly- backed effective weight loss biotech reports IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana use drug fails stage 2b, driving Indivior to reconsider $100M possibility

.Aelis Farma's hopes of getting a fast, positive selection on a $one hundred million alternative set...

ProKidney standstills period 3 trial certainly not required for cell therapy confirmation

.ProKidney has actually quit one of a set of stage 3 trials for its own cell therapy for renal illne...

Vaxcyte climbs on 'impressive' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what professionals called "spectacular" stage 1/2 records for its 31-valent pneumo...

Recursion's brain condition trial shows insufficient proof of efficiency

.Recursion has discovered by means of a very early test of its tech-enabled technique to medication ...

Acepodia, Pfizer click on with each other for chemistry-based tissue treatment

.Phone it a scenario of good chemical make up: Acepodia, a biotech based upon Nobel Champion scienti...

Praxis epilepsy medicine decreases confiscations in period 2 hearing

.Practice Accuracy Medicines has actually scored yet another midphase succeed in epilepsy this year,...

Three execs surrender as Dyne messages blended records for DMD applicant

.After running away a professional hold a number of years back, Dyne Therapeutics has actually revea...

Arrowhead fires off stage 3 records in unusual metabolic disease ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own give ahead of a possible showdown with Ionis, releas...